Histoplasma capsulatum Encodes a Dipeptidyl Peptidase Active against the Mammalian Immunoregulatory Peptide, Substance P

PLoS ONE

Volumn 4, Issue 4, 2009, Pages

  Cooper, Kendal G ^a   Zarnowski, Robert ^b   Woods, Jon P ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF TEXAS PAN AMERICAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PRIMER DNA; RECOMBINANT PROTEIN; SUBSTANCE P;

ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; ENZYME STABILITY; ENZYMOLOGY; FEMALE; GENETICS; HISTOPLASMA; HISTOPLASMOSIS; HYDROLYSIS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MOLECULAR CLONING; MOUSE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PH; POLYMERASE CHAIN REACTION; TEMPERATURE; VIRULENCE;

ANIMALS; ANTIGENS, CD26; BASE SEQUENCE; BLOTTING, NORTHERN; CLONING, MOLECULAR; DISEASE MODELS, ANIMAL; DNA PRIMERS; ENZYME STABILITY; FEMALE; HISTOPLASMA; HISTOPLASMOSIS; HYDROGEN-ION CONCENTRATION; HYDROLYSIS; MICE; MICE, INBRED C57BL; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SUBSTANCE P; TEMPERATURE; VIRULENCE;

EID: 67649230240     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0005281     Document Type: Article

References (34)

1. Cano MV, Hajjeh RA, (2001) The epidemiology of histoplasmosis: a review. Semin Respir Infect 16: 109-118.
2. Gorrell MD, Gysbers V, McCaughan GW, (2001) CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes. Scand J Immunol 54: 249-264.
3. Grouzmann E, Monod M, Landis B, Wilk S, Brakch N, et al.(2002) Loss of dipeptidylpeptidase IV activity in chronic rhinosinusitis contributes to the neurogenic inflammation induced by substance P in the nasal mucosa. FASEB J 10.1096/fj.01-0939fje.
4. Sandor M, Weinstock JV, Wynn TA, (2003) Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol 24: 44-52.
5. Weinstock JV, (2004) The role of substance P, hemokinin and their receptor in governing mucosal inflammation and granulomatous responses. Frontiers Bioscience 9: 1936-1943.
6. Christensen JE, Steele JL, (2003) Impaired growth rates in milk of Lactobacillus helveticus peptidase mutants can be overcome by use of amino acid supplements. J Bacteriol 185: 3297-3306.
7. Yagishita H, Kumagai Y, Konishi K, Takahashi Y, Aoba T, et al.(2001) Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant. Infect Immun 69: 7159-7161.
8. Kumagai Y, Konishi K, Gomi T, Yagishita H, Yajima A, et al.(2000) Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence. Infect Immun 68: 716-724.
9. Kumagai Y, Yagishita H, Yajima A, Okamoto T, Konishi K, (2005) Molecular mechanism for connective tissue destruction by dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis. Infect Immun 73: 2655-2664.
10. Retallack DM, Woods JP, (1999) Transcript splicing is essential for functional Histoplasma capsulatum URA5 expression. Gene 230: 181-185.
11. Woods JP, Heinecke EL, Goldman WE, (1998) Electrotransformation and expression of bacterial genes encoding hygromycin phosphotransferase and beta-galactosidase in the pathogenic fungus Histoplasma capsulatum. Infect Immun 66: 1697-1707.
12. Zarnowski R, Cooper KG, Brunold LS, Calaycay J, Woods JP, (2008) Histoplasma capsulatum secreted gamma-glutamyltransferase reduces iron by generating an efficient ferric reductant. Mol Microbiol 70: 352-368.
13. Chien CH, Tsai CH, Lin CH, Chou CY, Chen X, (2006) Identification of hydrophobic residues critical for DPP-IV dimerization. Biochemistry 45: 7006-7012.
14. Aertgeerts K, Ye S, Shi L, Prasad SG, Witmer D, et al.(2004) N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. Protein Sci 13: 145-154.
15. Wang LH, Ahmad S, Benter IF, Chow A, Mizutani S, et al.(1991) Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 12: 1357-1364.
16. Ahmad S, Wang L, Ward PE, (1992) Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo. J Pharmacol Exp Ther 260: 1257-1261.
17. Bohse ML, Woods JP, (2007) RNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defects. Infect Immun 75: 2811-2817.
18. Rementeria A, Lopez-Molina N, Ludwig A, Vivanco AB, Bikandi J, et al.(2005) Genes and molecules involved in Aspergillus fumigatus virulence. Rev Iberoam Micol 22: 1-23.
19. Beauvais A, Monod M, Wyniger J, Debeaupuis JP, Grouzmann E, et al.(1997) Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans. Infect Immun 65: 3042-3047.
20. Landis BN, Grouzmann E, Monod M, Busso N, Petak F, et al.(2008) Implication of dipeptidylpeptidase IV activity in human bronchial inflammation and in bronchoconstriction evaluated in anesthetized rabbits. Respiration 75: 89-97.
21. Zarnowski R, Connolly PA, Wheat LJ, Woods JP, (2007) Production of extracellular proteolytic activity by Histoplasma capsulatum grown in Histoplasma-macrophage medium is limited to restriction fragment length polymorphism class 1 isolates. Diagn Microbiol Infect Dis 59: 39-47.
22. Hube B, Monod M, Schofield DA, Brown AJ, Gow NA, (1994) Expression of seven members of the gene family encoding secretory aspartyl proteinases in Candida albicans. Mol Microbiol 14: 87-99.
23. Naglik J, Albrecht A, Bader O, Hube B, (2004) Candida albicans proteinases and host/pathogen interactions. Cell Microbiol 6: 915-926.
24. Kaufman G, Berdicevsky I, Woodfolk JA, Horwitz BA, (2005) Markers for host-induced gene expression in Trichophyton dermatophytosis. Infect Immun 73: 6584-6590.
25. Tartar A, Boucias DG, (2004) A pilot-scale expressed sequence tag analysis of Beauveria bassiana gene expression reveals a tripeptidyl peptidase that is differentially expressed in vivo. Mycopathologia 158: 201-209.
26. Weinstock JV, Elliott D, (1998) The substance P and somatostatin interferon-gamma immunoregulatory circuit. Ann N Y Acad Sci 840: 532-539.
27. Cascieri MA, Huang RR, Fong TM, Cheung AH, Sadowski S, et al.(1992) Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 41: 1096-1099.
28. Dickerson C, Undem B, Bullock B, Winchurch RA, (1998) Neuropeptide regulation of proinflammatory cytokine responses. J Leukoc Biol 63: 602-605.
29. Blum AM, Metwali A, Cook G, Mathew RC, Elliott D, et al.(1993) Substance P modulates antigen-induced, IFN-gamma production in murine Schistosomiasis mansoni. J Immunol 151: 225-233.
30. Bhatia M, Zhi L, Zhang H, Ng SW, Moore PK, (2006) Role of substance P in hydrogen sulfide-induced pulmonary inflammation in mice. Am J Physiol Lung Cell Mol Physiol 291: L896-904.
31. Lambeir AM, Durinx C, Proost P, Van Damme J, Scharpe S, et al.(2001) Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion. FEBS Lett 507: 327-330.
32. Reinke E, Fabry Z, (2006) Breaking or making immunological privilege in the central nervous system: the regulation of immunity by neuropeptides. Immunol Lett 104: 102-109.
33. Oravecz T, Pall M, Roderiquez G, Gorrell MD, Ditto M, et al.(1997) Regulation of the receptor specificity and function of the chemokine RANTES (regulated on activation, normal T cell expressed and secreted) by dipeptidyl peptidase IV (CD26)-mediated cleavage. J Exp Med 186: 1865-1872.
34. Struyf S, Proost P, Schols D, De Clercq E, Opdenakker G, et al.(1999) CD26/dipeptidyl-peptidase IV down-regulates the eosinophil chemotactic potency, but not the anti-HIV activity of human eotaxin by affecting its interaction with CC chemokine receptor 3. J Immunol 162: 4903-4909.